Acute intermittent porphyria is a defect of hepatic uroporphyrinogen I synthase activity.
- Porphobilinogen (the substrate) accumulates, and is excreted in the urine. Note: analysis of the urine for porphobilinogen is relatively simple.
- Heme synthesis is reduced. As a result, there is no feedback inhibition of ALA synthase, nor is there repression of synthesis of the enzyme protein. ALA synthase activity therefore increases.
- Insufficient 5-a steroid reductase activity shunts steroids into the 5-b reductase pathway, whose products further stimulate ALA synthase.
- There are neurological symptoms, including agitation, which cannot be explained. Administration of barbiturates to sedate an agitated patient would be counterproductive, as it would further activate ALA synthase, and result in more rapid clinical deterioration.
|
|